Skip to content
Screener

Arvinas ARVN Current Debt

Current Debt at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$1.58M-17.0%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$572.13M+18.3%
Enterprise value$493.43M+30.3%
P/S6.4×+5.1×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%—

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0×0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The source filing: Arvinas’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:18 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033669
(dollars in millions)Maturity DateInterest RateMarch 31,2026December 31,2025
2018 Assistance Agreement Debt09/283.25%$0.5$0.6
Less: current installments included within Accounts payable and accrued liabilities(0.2)(0.2)
Total long-term debt$0.3$0.4

Item 1. Financial Statements (Unaudited)

FAQ

What is Arvinas's current debt?
Arvinas (ARVN) reported current debt of $200K in Q1 2026.
How has Arvinas's current debt changed year-over-year?
Arvinas's current debt decreased by 0.0% year-over-year, from $200K to $200K.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about Arvinas's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude